News
Researchers at the Paul Scherrer Institute PSI have developed an AI that could open up a new, cost-effective approach to ...
Unlike other pathologies, amyotrophic lateral sclerosis (ALS) cannot be reproduced accurately in animal models, complicating ...
Bioengineers at Queen Mary University of London have taken a significant step forward in the development of laboratory-based ...
3d
AZoLifeSciences on MSNAI Designs Synthetic DNA to Control Gene Expression in Mammalian CellsA study published today in the journal Cell marks the first reported instance of generative AI designing synthetic molecules that can successfully control gene expression in healthy mammalian cells.
The medical research on human subjects has to respect the ethical principles included in the Declaration of Helsinki and the additional constraints imposed ...
No portion of this site may be copied, retransmitted, reposted, duplicated or otherwise used without the express written permission of Design And Reuse.
LONDON & BUDAPEST, Hungary--(BUSINESS WIRE)--In a landmark move, the FDA recently announced plans to phase out the requirement for animal testing ... a foundational cell model that allows ...
genetically modifiable and can be used to evaluate many genetic changes in AVM from VEGF‐induced angiogenesis to the maturation of endothelial cells in developing brain. For these reasons, mice are ...
The experiments in animal models demonstrated not only enhancement of NK cells but also that these cells can be transferred to naïve animals resulting in tumor eradication. The filed patent ...
Chimeric antigen receptor T (CAR-T) cell therapy targeting CD19 can significantly improve the long-term survival rate of patients with relapsed or refractory leukemia. However, CD19 absence or loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results